Our understanding of microbiology, chemistry, and toxicology have led to the creation of medical products and drugs that help in control, prevention, and treatment of infection, reduce topical pain, itch, and accelerate wound healing.

Our proprietary antimicrobial platforms are highly effective against gram-positive and gram-negative bacteria including antibiotic resistant strains, viruses, fungi, spores in presence of 5% serum.

Product uniquely designed to improve the spread of infectious diseases according to Center for Disease Control (CDC) “HAIs are infections resulting from complications of healthcare. They are linked with high morbidity and mortality. On any given day, 1 in 31 hospital patients has an HAI (an infection while being treated in a medical facility). Additional infections occur in other healthcare settings. Many HAIs are caused by the most serious antibiotic-resistant bacteria and can lead to sepsis or death.”

“HAIs in U.S. hospitals have direct medical costs of at least $28.4 billion each year. They also account for an additional $12.4 billion in costsexternal icon to society from early deaths and lost productivity.”

We have created products to prevent and treat infections and potentially reshape the standard of care. They were designed to treat or reduce the risk of infections in surgical sites, invasive surgeries, burn and wound care, dermatology, ophthalmology and as non-alcohol hand sanitizer.